Literature DB >> 19956190

Health policy: The UK 'postcode lottery' in renal cell carcinoma.

James Larkin, Martin Gore.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19956190     DOI: 10.1038/nrurol.2009.228

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN: 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  3 in total

1.  Sorafenib in advanced clear-cell renal-cell carcinoma.

Authors:  Bernard Escudier; Tim Eisen; Walter M Stadler; Cezary Szczylik; Stéphane Oudard; Michael Siebels; Sylvie Negrier; Christine Chevreau; Ewa Solska; Apurva A Desai; Frédéric Rolland; Tomasz Demkow; Thomas E Hutson; Martin Gore; Scott Freeman; Brian Schwartz; Minghua Shan; Ronit Simantov; Ronald M Bukowski
Journal:  N Engl J Med       Date:  2007-01-11       Impact factor: 91.245

2.  Sunitinib versus interferon alfa in metastatic renal-cell carcinoma.

Authors:  Robert J Motzer; Thomas E Hutson; Piotr Tomczak; M Dror Michaelson; Ronald M Bukowski; Olivier Rixe; Stéphane Oudard; Sylvie Negrier; Cezary Szczylik; Sindy T Kim; Isan Chen; Paul W Bycott; Charles M Baum; Robert A Figlin
Journal:  N Engl J Med       Date:  2007-01-11       Impact factor: 91.245

3.  Effect of the UK postcode lottery on survival of patients with metastatic renal cancer: an audit of outcomes in patients with metastatic renal cancer suitable for treatment with tyrosine kinase inhibitors.

Authors:  N James; J Pascoe; A Zachariah; D Ray; A Oldroyd; H Parry; H Benghiat; M Karina; S Collins; E Porfiri
Journal:  Clin Oncol (R Coll Radiol)       Date:  2009-08-19       Impact factor: 4.126

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.